Pfizer sues Teva over arthritis treatment

17-02-2022

Alex Baldwin

Pfizer sues Teva over arthritis treatment

nitpicker / Shutterstock.com

Pfizer has sued Teva Pharmaceuticals, alleging that the Israeli pharma company is planning on releasing a generic of Pfizer’s Xeljanz XR (Tofacitinib Citrate) arthritis treatment before the branded drug’s key patent expires.


Teva Pharmaceuticals, Pfizer, Xeljanz, US District Court or the District of Delaware

LSIPR